Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report.
Yoshifumi HidakaMiyo TomitaRyosuke DesakiMasahiro HamanoueSonshin TakaoMari KirishimaTakao OhtsukaPublished in: World journal of surgical oncology (2022)
CS with atezolizumab plus bevacizumab therapy has potential utility for the treatment of unresectable HCC with PVTT.